-
公开(公告)号:DE69909897T2
公开(公告)日:2004-05-27
申请号:DE69909897
申请日:1999-05-14
Applicant: IDEXX LAB INC
Inventor: GROAT RANDALL G , MERMER BRION , O'CONNOR THOMAS P
IPC: C07K7/08 , C07K14/155 , G01N33/569
Abstract: We disclose methods for determining whether a feline is infected with feline immunodeficiency virus ("FIV"). The methods involve the use of an antibody-binding composition that includes two enhanced polypeptides, one containing an immunogenic fragment of the FIV gag precursor p55 and the other containing an immunogenic fragment of the FIV env precursor gp130. Also disclosed are devices for practising these methods.
-
公开(公告)号:AU757334B2
公开(公告)日:2003-02-13
申请号:AU4044900
申请日:2000-03-30
Applicant: IDEXX LAB INC
Inventor: LAWTON ROBERT , MERMER BRION , FRANCOEUR GREG
-
公开(公告)号:AU3310201A
公开(公告)日:2001-08-14
申请号:AU3310201
申请日:2001-01-30
Applicant: IDEXX LAB INC
Inventor: LAWTON ROBERT L , AIYAPPA ASHOK P , LIU WENDY W , MERMER BRION , GUO HONGLIANG , KRAH EUGENE R III
Abstract: The present invention provides methods and compositions for decreasing IgE levels in dogs. The methods and compositions are useful for treating allergic symptoms in dogs. The invention may comprise chimeric canine anti-IgE monoclonal antibody compositions and methods for using the compositions in the treatment of allergy. In preferred embodiments, the compositions of the present invention may act by binding soluble IgE in plasma, or by inhibiting IgE from binding to receptors on mast cells, B cells, and basophils.
-
公开(公告)号:AU4053600A
公开(公告)日:2000-10-16
申请号:AU4053600
申请日:2000-03-30
Applicant: IDEXX LAB INC
Inventor: LAWTON ROBERT , MERMER BRION , FRANCOEUR GREG , KRAH REGIS
-
公开(公告)号:CA2329152A1
公开(公告)日:2000-10-05
申请号:CA2329152
申请日:2000-03-30
Applicant: IDEXX LAB INC
Inventor: LAWTON ROBERT , KRAH REGIS , FRANCOEUR GREG , MERMER BRION
IPC: C12P21/08 , A61K38/00 , A61K39/00 , A61P37/08 , C07K7/06 , C07K7/08 , C07K16/06 , C07K16/28 , C07K16/44 , C12N7/00 , A61K39/395
Abstract: Disclosed is an isolated and purified peptide comprising a leucine positione d two peptide bonds away from a tyrosine-arginine pair, such as having the configuration: leucine-blank-blank-tyrosine-arginine, tyrosine-arginine-blan k- blank-leucine, or, leucine-blank-blank-tyrosine-arginine-blank-blank-leucine , where blank is any amino acid. Other peptides of the invention include those with the sequence cysteine-blank-blank-proline-histidine-blank-blank-blank- cysteine; cysteine-blank-proline-histidine-blank-proline-blank-blank-cystein e. The peptides can be linked to a carrier such as a multiply antigen protein o r a plant virus particle. Isolated and purified peptides of the invention can be used to induce canine autoantibodies directed to the canine igE molecule.
-
公开(公告)号:CA2329148A1
公开(公告)日:2000-10-05
申请号:CA2329148
申请日:2000-03-30
Applicant: IDEXX LAB INC
Inventor: MERMER BRION , FRANCOEUR GREG , LAWTON ROBERT
Abstract: Disclosed are binding proteins that specifically bind to an isolated and purified peptide comprising a leucine positioned two peptide bonds away from a tyrosine-arginine pair. Other binding proteins of the invention include those that specifically bind to an isolated and purified peptide with the sequence cysteine-blank-blank-proline-histidine-blank-blank-blank-cysteine (SEQ ID NO:6) or cysteine-blank-proline-histidine-blank-proline-blank-blank-cysteine (SEQ ID NO:9).
-
-
-
-
-